Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 8:00 PM JST
Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61L9/00 AND EN_ALLTXT:(coronavirus OR coronaviruses OR coronaviridae OR coronavirinae OR orthocoronavirus OR orthocoronaviruses OR orthocoronaviridae OR orthocoronavirinae OR betacoronavirus OR betacoronaviruses OR betacoronaviridae OR betacoronavirinae OR sarbecovirus OR sarbecoviruses OR sarbecoviridae OR sarbecovirinae OR "severe acute respiratory syndrome" OR sars OR "2019 ncov" OR covid)

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.WO/2021/226232AERIAL DISINFECTION
WO 11.11.2021
Int.Class A61L 9/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
9Disinfection, sterilisation or deodorisation of air
14using sprayed or atomised substances
Appl.No PCT/US2021/030881 Applicant GRIGNARD PURE LLC Inventor GRIGNARD III, Emile Etienne
This disclosure relates to a method for disinfecting a space. The method includes spraying a composition containing triethylene glycol into a space containing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an amount effective to inactivate SARS-CoV-2.
2.WO/2022/005875CHLORITE IN THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME
WO 06.01.2022
Int.Class C01B 11/10
CCHEMISTRY; METALLURGY
01INORGANIC CHEMISTRY
BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF
11Oxides or oxyacids of halogens; Salts thereof
08Chlorous acid
10Chlorites
Appl.No PCT/US2021/038959 Applicant THE REGENTS OF THE UNIVERSITY OF CALIFORNIA Inventor MCGRATH, Michael S.
Disclosed herein are methods of treating a subject having, or at risk of developing, acute respiratory distress syndrome (ARDS) by administering a chlorite composition in an amount effective to treat the subject. Aspects of the methods also include administering a chlorite formulation to a subject having or suspected of having a coronavirus infection, e.g., severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome (SARS-CoV), or Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Also disclosed herein are methods of regulating macrophage activity in a subject having, or at risk of developing ARDS by contacting a macrophage of a subject having or at risk of developing ARDS with a chlorite composition in an amount effective to regulate one or more functional properties of the macrophage. The disclosure also features methods of determining inhibition of a ARDS-induced macrophage activity by a chlorite agent.
3.20210338708METHOD FOR TREATMENT OF CORONAVIRUS INFECTION
US 04.11.2021
Int.Class A61K 31/714
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7135Compounds containing heavy metals
714Cobalamins, e.g. cyanocobalamin, vitamin B12
Appl.No 17205521 Applicant Renibus Therapeutics, Inc. Inventor Donald Jeffrey KEYSER

The present invention involves a novel method for treatment of coronavirus infection, including SARS-COV-2. The method comprises administering stannous protoporphyrin and/or cyanocobalamin to a human patient at risk for developing complications from coronavirus infection. The method is particularly useful where a patient has been diagnosed with coronavirus infection or has been exposed to coronavirus but has not developed symptoms of coronavirus infection.

4.WO/2021/224673SUBSTANCE AND METHOD FOR PREVENTING THE TRANSMISSION OF VIRUSES IN THE RESPIRATORY SYSTEM
WO 11.11.2021
Int.Class A61L 2/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
2Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
Appl.No PCT/IB2020/061260 Applicant CO2APPS S.R.L. Inventor CAPPELLO, Giovanni
The invention relates to a system for generating air adapted to prevent the infection of airborne viruses in an indoor environment. The system comprises an aerosol generator, at least one air aerosol concentration meter and at least one control unit. The supply means provide a certain flow rate of sodium bicarbonate (NaHCO3) saline solution to the aerosol generator. The aerosol generator generates a drop aerosol of a saline solution which is conveyed into the indoor environment and can be breathed by individuals. The aerosol concentration meter provides the control unit with a measurement of the concentration of aerosol drops in the air in the indoor environment. The control unit controls the aerosol generation means so that they supply the appropriate amount of aerosol in the indoor environment to obtain a predetermined sodium bicarbonate (NaHCO3) concentration. The invention also relates to a method for preventing the transmission of the infection.
5.20210338715PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF COVID-19
US 04.11.2021
Int.Class A61K 33/20
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
20Elemental chlorine; Inorganic compounds releasing chlorine
Appl.No 16927613 Applicant RADINOR, LLC Inventor Andreas Ludwig Kalcker

The invention relates to a pharmaceutical composition based on a chlorine dioxide solution, for use as a therapeutic agent in the topical, oral, and/or parenteral treatment of viral infections of the human or animal body, caused by SARS-CoV-2 coronaviruses.

6.20220008854ANTIVIRAL FILTER MEDIUM
US 13.01.2022
Int.Class B01D 46/00
BPERFORMING OPERATIONS; TRANSPORTING
01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
DSEPARATION
46Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
Appl.No 17367436 Applicant Carl Freudenberg KG Inventor Uwe Haefner

A method includes: using a planar substrate having at least one acid-functionalized layer including at least one first acid having a pks1 value of 0 to 7 and at least one different second acid or derivative thereof selected from a group consisting of C8 to C18 fatty acids, esters, amides, and mixtures thereof, as a filter medium for depleting viruses from air and other gases.

7.20040234457Methods of preventing and treating SARS using low pH respiratory tract compositions
US 25.11.2004
Int.Class A61K 9/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
Appl.No 10770138 Applicant The Procter & Gamble Company Inventor Rennie Paul John

The present invention is directed to methods of preventing and treating Severe Acute Respiratory Syndrome (SARS) by the administration of respiratory tract compositions having low pH values. The respiratory tract compositions have a pH of from about 3.0 to about 5.5, and are preferably administered to areas of the respiratory tract such as the nasal cavity to effectively prevent and treat respiratory tract viral infections, particularly SARS. The respiratory tract compositions comprise an organic acid in combination with a metal compound.

8.10919020Air filters with functionalized nanotube compositions to control pathogens such as SARS CoV-2 (coronavirus)
US 16.02.2021
Int.Class B01D 46/00
BPERFORMING OPERATIONS; TRANSPORTING
01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
DSEPARATION
46Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
Appl.No 16942974 Applicant MOLECULAR REBAR DESIGN, LLC Inventor Kurt W. Swogger

Nanotube compositions may be employed in many different forms alone, and/or with surfactants, with antiviral metals, with antigens, and/or with various drugs to control pathogens like viruses e.g., SARS COVID-2, bacteria, mold, fungi, chemical or biological agents etc in masks or other personal protection equipment. The personal protection equipment such as masks reduce, control, absorb, deactivate, detoxify, and/or kill the pathogens such that a pathogen or pathogens deleterious effects are reduced and/or eliminated to a user of the mask.

9.2580006Bubbles for air decontamination
GB 08.07.2020
Int.Class A61L 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
9Disinfection, sterilisation or deodorisation of air
Appl.No 202006266 Applicant MICHAEL ANTHONY HOLMES Inventor MICHAEL ANTHONY HOLMES
A method of decontaminating air from lipophilic airborne contaminants (e.g. lipid enveloped virus) comprising delivering soap bubbles into the air, wherein the soap bubbles comprise a solvent and a surfactant. Preferably the surfactant is sodium laureth sulphate and/or sodium lauryl sulphate. The soap bubbles may further comprise an evaporation suppressant such as glycerol, polyethylene glycol and/or corn syrup. In one embodiment the lipophilic airborne contaminants are lipid-coated viruses, such as coronaviruses like COVID-19. The method can be computer-implemented and comprises a decontamination signal transmitter which transmits a wired or wireless decontamination activation signal to the air decontamination apparatus, which in response, produces and delivers soap bubbles into the air. There may optionally be a decontamination deactivation signal which ceases production of the soap bubbles.
10.113201068Gene recombinant IgY for resisting 2019-nCoV and other coronaviruses and small molecular antibody and application thereof
CN 03.08.2021
Int.Class C07K 16/10
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
08against material from viruses
10from RNA viruses
Appl.No 202010078398.6 Applicant SHENZHEN YACHEN INTELLIGENT BIOLOGICAL ENGINEERING CO., LTD. Inventor BAO SHENG
The invention relates to a gene recombinant IgY for resisting '2019-nCoV' and other coronaviruses, a small molecular antibody, a preparation method and application thereof. The IgY for resisting '2019-nCoV' and other coronaviruses and the small molecule antibody thereof can directly inhibit and kill '2019-nCoV' and other coronaviruses and close key protein S protein and RBD structural domain of the key protein S protein, acting with host cells, of the coronaviruses, so that the key protein S protein cannot be combined with a cell membrane receptor ACE2; therefore, the infection of the respiratory epithelial cells by '2019-nCoV' and other coronaviruses is prevented. Meanwhile, the antibodies can neutralize coronavirus discharged by infected cells and block secondary infection and diffusion propagation. The invention further provides an atomizing agent, a spray, a mouth spray, a nasal spray, a nose drop, an eye drop, an air disinfectant, a hand sanitizer, powder, tablets, buccal tablets, oral liquid and capsules prepared from the IgY resisting the 2019-nCoV and other coronaviruses and the small molecule antibody of the IgY. The IgY is applied to drugs, disinfection products, health care products and medical instruments for preventing and treating infection of the 2019-nCoV and other coronaviruses.